| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $510.7M | +1.6% |
| Cost of Revenue | $389.6M | +2.8% |
| Gross Profit | $121.1M | -1.9% |
| R&D Expense | $11.8M | +64.7% |
| SG&A Expense | $110.4M | +2.2% |
| Operating Income | -$142.1M | -1685.4% |
| Pre-tax Income | -$1.44B | -484.6% |
| Income Tax | $859K | +25.8% |
| Net Income | -$1.44B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $836.2M | +1558.8% |
| Accounts Receivable | $1.0M | +2.4% |
| Current Assets | $904.0M | +831.8% |
| Total Assets | $1.48B | +107.3% |
| Current Liabilities | $134.6M | -72.4% |
| Total Liabilities | $2.42B | +84.8% |
| Stockholders' Equity | -$943.0M | -58.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.9M | -34.1% |
| Capital Expenditures | $95.0M | +487.6% |
| Investing Cash Flow | -$95.2M | -3077.3% |
| Financing Cash Flow | $819.6M | +1935.6% |
| Free Cash Flow | -$52.1M | -206.4% |
| -483.3% |
| EPS (Basic) | -$4.87 | -649.2% |
| EPS (Diluted) | -$4.87 | -649.2% |